FarmavitaR+

regulatory affairs network

  • Increase font size
  • Default font size
  • Decrease font size

NICE impact

E-mail Print PDF

datamonitor_logo.gifNICE: its impact on the UK healthcare system and beyond 

NICE is one of the most advanced cost effectiveness assessment bodies operating in the major pharmaceutical markets. Since it was established it has had an increasing impact on the availability of new drugs in England and Wales, but has also generated considerable attention globally.

NICE plays a key role in the UK healthcare system although it does not currently assess all new drug approvals. It's impact is also felt outside the UK as organizations and indeed individual physicians in other countries also monitor its conclusions.

A variety of stakeholders have input into the NICE topic selection process including patients, physicians and the pharmaceutical industry. To date cancer drugs have accounted for the largest number of completed assessments.

Read more...

 
Banner


Login With Facebook

Active Groups

{captcha}